NOLVADEX (20MG) (50 TABLETS)

Selective Estrogen Receptor Modulator (SERM) | Targeted Mammary Tissue Protection, HPTA Stimulation & Estrogen Receptor Antagonism

Overview:
Nolvadex (Tamoxifen Citrate) is a widely utilized Selective Estrogen Receptor Modulator (SERM) engineered to competitively bind to estrogen receptors throughout body tissues. By occupying receptor sites—particularly in breast tissue—Tamoxifen blocks circulating estradiol from exerting estrogenic effects without crushing systemic estrogen levels. Furthermore, it acts centrally at the hypothalamus and pituitary gland to block estrogenic negative feedback, stimulating the release of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) to reboot endogenous testosterone production.

This product is supplied as a secure bottle containing 50 oral tablets, with each tablet accurately dosed at 20mg of active Tamoxifen Citrate.

During or following androgenic protocols, elevated estrogen levels can trigger gynecomastia (breast tissue swelling) and suppress natural pituitary output. Unlike aromatase inhibitors that stop estrogen production entirely—which can negatively impact lipid profiles, bone density, and joint health—Nolvadex works as a tissue-selective antagonist. It blocks estrogen where it causes harm while acting as an estrogen agonist in the liver to help maintain healthy lipid profiles.

The 20mg tablet configuration is the universal gold standard for both acute gynecomastia prevention and post-cycle recovery (PCT) protocols. Having 50 tablets per container provides a convenient, long-term supply for full 4- to 6-week recovery protocols.

• Targeted Gynecomastia Prevention: Directly blocks estrogen receptors in breast tissue, stopping gland swelling, soreness, and tissue growth.
• HPTA Axis Recovery: Disinhibits the pituitary gland to increase LH and FSH secretion, driving natural testosterone restoration after suppression.
• Cardioprotective Lipid Support: Acts as an estrogen agonist in hepatic tissue, helping to maintain favorable HDL/LDL cholesterol balances.
• Preserves Systemic Estrogen Function: Protects joints, bone density, and vascular health by modulating receptors rather than crashing total circulating estrogen.
• Standard 20mg Strength: Ideal for flexible daily protocols (e.g., 20mg daily or splitting to 10mg micro-doses).

• Half-Life & Timing: Tamoxifen Citrate has an extended active elimination half-life of approximately 5 to 7 days. It is administered once daily with water, with or without meals.
• PCT Protocol Timing: Administration begins once synthetic androgenic compounds have cleared systemic circulation (timed according to the half-lives of the specific esters used).
• Common Dosing Structure: Standard post-protocol recovery typically utilizes 20mg to 40mg daily for 2 weeks, followed by 20mg to 10mg daily for an additional 2 to 4 weeks.
• Swallowing: Swallow whole with water. Do not crush or chew.

• Combination with AIs: While highly effective on its own, Tamoxifen can be combined with aromatase inhibitors if systemic estrogen reduction is also required during active cycles.
• Hormonal Blood Panels: Evaluating baseline and post-protocol levels of total/free testosterone, LH, FSH, and estradiol (E2) is strongly advised to confirm full endocrine recovery.
• Hydration: Maintain optimal fluid intake throughout the active protocol duration.